经肛门取出标本的改良达芬奇机器人手术系统直肠乙状结肠前切除术的临床疗效

Clinical efficacy of transanal specimen extraction in modified Da Vinci robot assisted anterior resection of rectosigmoid tumor

  • 摘要: 目的:探讨经肛门取出标本的改良达芬奇机器人手术系统直肠乙状结肠前切除术治疗直肠乙状结肠肿瘤的临床疗效。
    方法:采用回顾性横断面研究方法。收集2016年3—10月中南大学湘雅二医院收治的47例行经肛门取出标本的改良达芬奇机器人手术系统直肠乙状结肠前切除术的直肠乙状结肠肿瘤患者临床病理资料。术中切除肠管直接经肛门拖出,不取腹部小切口。观察指标:(1)手术及术后恢复情况。(2)术后病理学检查情况。(3)随访情况。采用门诊和电话方式进行随访,了解患者术后生存及肿瘤复发、转移情况。随访时间截至2017年6月。正态分布的计量资料采用±s表示。
    结果:(1)手术及术后恢复情况:47例患者均顺利完成手术,无一例中转开腹。47例患者中,8例行结肠肛管超低位吻合术; 3例行末端回肠预防性造瘘术;1例将拟切除标本外翻后行括约肌间切除术。47例患者手术时间为(222±73)min,术中出血量为(21±9)mL,术后首次下床活动时间为(1.7±0.8)d,术后肛门首次排气时间为(2.3±1.0)d,术后引流管拔除时间为(6±5)d。术后3例患者发生并发症,其中吻合口瘘2例,予保守治疗后痊愈;尿潴留1例,于术后4周拔除导尿管。47例患者肛门功能均恢复良好,术后住院时间为(10±4)d。(2)术后病理学检查情况:47例患者淋巴结清扫数目为(15±7)枚,均为R0切除。肿瘤病理学诊断:直肠乙状结肠腺癌38例(高分化1例、中分化32例、低分化5例),混合型癌4例,管状绒毛腺瘤2例,黏液腺癌1例,神经内分泌癌1例,灶癌1例。47例患者肿瘤最大直径为(3.5±1.5)cm。术后肿瘤病理学T分期:T1期 4例,T2期9例,T3期18例,T4a期14例。术后肿瘤病理学N分期:N0期30例,N1期8例,N2期7例。术后肿瘤病理学TNM分期:Ⅰ期11例,Ⅱ期19例,Ⅲ期15例。2例管状绒毛腺瘤无分期。(3)随访情况:47例患者中,42例获得术后随访,随访时间为7~15个月,中位随访时间为11个月。随访期间,38例患者无瘤生存,3例肿瘤复发或转移,1例死亡。
    结论:经肛门取出标本的改良达芬奇机器人手术系统直肠乙状结肠前切除术治疗直肠乙状结肠肿瘤安全可行,创伤小,近期疗效满意。

     

    Abstract: Objective:To explore the clinical efficacy of transanal specimen extraction in modified Da Vinci robotassisted anterior resection of rectosigmoid tumor.
    Methods:The retrospective crosssectional study was conducted. The clinicopathological data of 47 patients who underwent Da Vinci robotassisted anterior resection of rectosigmoid tumor using transanal specimen extraction in the Second Xiangya Hospital of Central South University from March to October 2016 were collected. Excisional intestinal canal was intraoperatively taken out from the anus instead of abdominal minor incision. Observation indicators: (1) operation and postoperative recovery; (2) postoperative pathological examination situations; (3) followup. Followup using outpatient examination and telephone interview was performed to detect postoperative survival of patients and tumor recurrence or metastasis up to June 2017. Measurement data with normal distribution were represented as ±s.
    Results:(1) Operation and postoperative recovery: 47 patients underwent successful operations, without conversion to open surgery. Of 47 patients, 8 underwent coloanal ultralow anastomosis, 3 underwent prophylactic terminal ileum stoma fistulization and 1 underwent intersphincteric resection after turning inside out resectable specimen. Operation time, volume of intraoperative blood loss, time for outofbed activity, time to anal exsufflation and time of postoperative drainagetube removal were (222±73)minutes, (21±9)mL, (1.7±0.8)days, (2.3±1.0)days and (6±5)days, respectively. Among 3 patients with postoperative complications, 2 with anastomotic fistula were cured by conservative treatment, and 1 with urinary retention removed urethra catheter at 4 weeks postoperatively. All the 47 patients had good recovery, and duration of hospital stay was (10±4)days. (2) Postoperative pathological examination situations: number of lymph node dissected was 15±7, with R0 resection. Tumor pathological diagnosis: rectosigmoid adenocarcinoma was detected in 38 patients (1 with highdifferentiated tumor, 32 with moderatedifferentiated tumor and 5 with lowdifferentiated tumor), mixed carcinoma in 4 patients, tubulovillous adenoma in 2 patients, mucinous adenocarcinoma in 1 patient, neuroendocrine carcinoma in 1 patient and focal carcinoma in 1 patient. The maximum diameter of tumor was (3.5±1.5)cm. Postoperative pathological T stage: 4, 9, 18 and 14 patients were detected in stage T1, T2, T3 and T4a. Postoperative pathological N stage: 30, 8 and 7 patients were detected in stage N0, N1 and N2. Postoperative pathological TNM stage: stage Ⅰ, Ⅱ and Ⅲ were respectively in 11, 19 and 15 patients. There was no clinical stage in 2 patients with tubulovillous adenoma. (3) Followup: of 47 patients, 42 were followed up for 7-15 months, with a median time of 11 months. During the followup, 38 patients had tumorfree survival, 3 had tumor recurrence or metastases and 1 died.
    Conclusion:Transanal specimen extraction is safe and feasible in modified Da Vinci robotassisted anterior resection of rectosigmoid tumor, with minimal invasion and satisfactory shortterm outcomes.

     

/

返回文章
返回